Literature DB >> 21664497

Idiopathic inflammatory myopathies: definition and management of refractory disease.

Mariana Brandão1, António Marinho.   

Abstract

Adult idiopathic inflammatory myopathies, commonly referred to as myositis, are a heterogeneous group of diseases with an autoimmune etiology. In this review, the authors are going to focus on myositis excluding inclusion body myositis. They will review the prognostic factors (for mortality and response to steroids), define refractory disease, introduce a new concept (presumed refractory disease), analyze definitions of active disease, damage and improvement criteria, and summarize therapeutic alternatives for refractory patients, based on different disease phenotypes.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21664497     DOI: 10.1016/j.autrev.2011.05.021

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  4 in total

1.  Quantitative T cell subsets profile in peripheral blood from patients with idiopathic inflammatory myopathies: tilting the balance towards proinflammatory and pro-apoptotic subsets.

Authors:  F Espinosa-Ortega; D Gómez-Martin; K Santana-De Anda; J Romo-Tena; P Villaseñor-Ovies; J Alcocer-Varela
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

Review 2.  Targeted immunotherapy trials for idiopathic inflammatory myopathies.

Authors:  Joerg-Patrick Stübgen
Journal:  J Neurol       Date:  2012-06-30       Impact factor: 4.849

3.  Thymoma may explain the confusion: a case report.

Authors:  Abdelkhaleq Maaroufi; Naoufal Assoufi; Mohamed Amine Essaoudi; Jamal Fatihi
Journal:  J Med Case Rep       Date:  2021-12-16

4.  Investigation into the cause of mortality in 49 cases of idiopathic inflammatory myopathy: A single center study.

Authors:  Yizhi Xiao; Xiaoxia Zuo; Yunhui You; Hui Luo; Liping Duan; Weiru Zhang; Yisha Li; Yanli Xie; Yaou Zhou; Wangbin Ning; Tong Li; Sijia Liu; Honglin Zhu; Ying Jiang; Siyao Wu; Hongjun Zhao
Journal:  Exp Ther Med       Date:  2016-01-18       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.